126 related articles for article (PubMed ID: 32691496)
1. Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer.
Gogineni E; Rana Z; Vempati P; Karten J; Sharma A; Taylor P; Pereira L; Frank D; Paul D; Seetharamu N; Ghaly M
Head Neck; 2020 Oct; 42(10):2880-2886. PubMed ID: 32691496
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy as primary treatment for elderly patients with medically inoperable head and neck cancer.
Vargo JA; Ferris RL; Clump DA; Heron DE
Front Oncol; 2014; 4():214. PubMed ID: 25157336
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiotherapy for medically unfit patients with cancers to the head and neck.
Al-Assaf H; Erler D; Karam I; Lee JW; Higgins K; Enepekides D; Zhang L; Eskander A; Poon I
Head Neck; 2020 Aug; 42(8):2050-2057. PubMed ID: 32199031
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy for head and neck skin cancer.
Voruganti IS; Poon I; Husain ZA; Bayley A; Barnes EA; Zhang L; Chin L; Erler D; Higgins K; Enepekides D; Eskander A; Karam I
Radiother Oncol; 2021 Dec; 165():1-7. PubMed ID: 34648871
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
6. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
[TBL] [Abstract][Full Text] [Related]
7. Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer.
Franzese C; Badalamenti M; Teriaca A; De Virgilio A; Mercante G; Cavina R; Ferrari D; Santoro A; Spriano G; Scorsetti M
J Cancer Res Clin Oncol; 2021 May; 147(5):1307-1313. PubMed ID: 33471186
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review.
Kim MS; Malik NH; Chen H; Poon I; Husain Z; Eskander A; Boldt G; Louie AV; Karam I
Head Neck; 2022 Mar; 44(3):770-782. PubMed ID: 34927313
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.
Lee DS; Kim YS; Cheon JS; Song JH; Son SH; Jang JS; Kang YN; Kang JH; Jung SL; Yoo IeR; Jang HS
Radiat Oncol; 2012 Jun; 7():85. PubMed ID: 22691266
[TBL] [Abstract][Full Text] [Related]
11. Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.
Swaminath A; Wierzbicki M; Parpia S; Wright JR; Tsakiridis TK; Okawara GS; Kundapur V; Bujold A; Ahmed N; Hirmiz K; Kurien E; Filion E; Gabos Z; Faria S; Louie AV; Owen T; Wai E; Ramchandar K; Chan EK; Julian J; Cline K; Whelan TJ
Clin Lung Cancer; 2017 Mar; 18(2):250-254. PubMed ID: 27876603
[TBL] [Abstract][Full Text] [Related]
12. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
[TBL] [Abstract][Full Text] [Related]
13. Role of stereotactic body radiotherapy for symptom control in head and neck cancer patients.
Khan L; Tjong M; Raziee H; Lee J; Erler D; Chin L; Poon I
Support Care Cancer; 2015 Apr; 23(4):1099-103. PubMed ID: 25294656
[TBL] [Abstract][Full Text] [Related]
14. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
[TBL] [Abstract][Full Text] [Related]
15. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
[TBL] [Abstract][Full Text] [Related]
16. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
[TBL] [Abstract][Full Text] [Related]
17. A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.
Macchia G; Lazzari R; Colombo N; Laliscia C; Capelli G; D'Agostino GR; Deodato F; Maranzano E; Ippolito E; Ronchi S; Paiar F; Scorsetti M; Cilla S; Ingargiola R; Huscher A; Cerrotta AM; Fodor A; Vicenzi L; Russo D; Borghesi S; Perrucci E; Pignata S; Aristei C; Morganti AG; Scambia G; Valentini V; Jereczek-Fossa BA; Ferrandina G
Oncologist; 2020 Feb; 25(2):e311-e320. PubMed ID: 32043791
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
20. Quality of Life Outcomes Following Organ-Sparing SBRT in Previously Irradiated Recurrent Head and Neck Cancer.
Gogineni E; Zhang I; Rana Z; Marrero M; Gill G; Sharma A; Riegel AC; Teckie S; Ghaly M
Front Oncol; 2019; 9():836. PubMed ID: 31552172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]